Back to search
FDAFDA · Food and drugs·Recall number D-0583-2024

Allopurinol Tablets, USP 300mg, 100 Tablets per bottle, Rx only, Manufactured By: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106 USA, NDC 55111-730-01.

Published July 10, 2024 · Recall initiated: June 7, 2024

Summary

FDA records drug Class II recall D-0583-2024, published July 10, 2024 and initiated June 7, 2024. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 20,520 units; Lot: L2300594. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of foreign substance.

What to do

Voluntary: Firm initiated · Letter

Get an email if ALLOPURINOL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ALLOPURINOL
Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
IL, MS, OH
UPC
0355111729013
Lot
L2300594
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Allopurinol Tablets, USP 300mg, 100 Tablets per bottle, Rx only, Manufactured By: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106 USA, NDC 55111-730-01. recalled?

Yes. FDA published recall D-0583-2024 on July 10, 2024. Reported hazard: Presence of foreign substance.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ALLOPURINOL. UPC: 0355111729013.